BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 11112155)

  • 1. Hepatocyte growth factor attenuates collagen accumulation in a murine model of pulmonary fibrosis.
    Dohi M; Hasegawa T; Yamamoto K; Marshall BC
    Am J Respir Crit Care Med; 2000 Dec; 162(6):2302-7. PubMed ID: 11112155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imbalance in the pro-hepatocyte growth factor activation system in bleomycin-induced lung fibrosis in mice.
    Phin S; Marchand-Adam S; Fabre A; Marchal-Somme J; Bantsimba-Malanda C; Kataoka H; Soler P; Crestani B
    Am J Respir Cell Mol Biol; 2010 Mar; 42(3):286-93. PubMed ID: 19448157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bleomycin-induced pulmonary fibrosis is attenuated by an antibody against KL-6.
    Xu L; Yang D; Zhu S; Gu J; Ding F; Bian W; Rong Z; Shen C
    Exp Lung Res; 2013 Aug; 39(6):241-8. PubMed ID: 23672275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous or delayed administration of hepatocyte growth factor equally represses the fibrotic changes in murine lung injury induced by bleomycin. A morphologic study.
    Yaekashiwa M; Nakayama S; Ohnuma K; Sakai T; Abe T; Satoh K; Matsumoto K; Nakamura T; Takahashi T; Nukiwa T
    Am J Respir Crit Care Med; 1997 Dec; 156(6):1937-44. PubMed ID: 9412578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HGF reduces advancing lung fibrosis in mice: a potential role for MMP-dependent myofibroblast apoptosis.
    Mizuno S; Matsumoto K; Li MY; Nakamura T
    FASEB J; 2005 Apr; 19(6):580-2. PubMed ID: 15665032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biphasic effects of free radical scavengers against bleomycin-induced pulmonary fibrosis.
    Fujita M; Mizuta Y; Ikegame S; Ouchi H; Ye Q; Harada E; Inoshima I; Yoshimi M; Watanabe K; Nakanishi Y
    Pulm Pharmacol Ther; 2008 Oct; 21(5):805-11. PubMed ID: 18655842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of intramuscular injection of hepatocyte growth factor plasmid DNA with electroporation on bleomycin-induced lung fibrosis in rats.
    Long X; Xiong SD; Xiong WN; Xu YJ
    Chin Med J (Engl); 2007 Aug; 120(16):1432-7. PubMed ID: 17825173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of valsartan on bleomycin-induced pulmonary fibrosis in rats and the expression of hepatocyte growth factor in lung tissue].
    Liu F; Xu QY; Ye YQ
    Zhonghua Jie He He Hu Xi Za Zhi; 2005 Jul; 28(7):479-83. PubMed ID: 16115399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of 1, 25 (OH)2D3 on bleomycin-induced pulmonary fibrosis in mice].
    Zhang ZM; Gu P; Yi XH; Fang X; Zeng Y; Zhang SX; Zhu XY; Zhang YD; Gu J; Qiu WZ; Zhang L
    Zhonghua Jie He He Hu Xi Za Zhi; 2013 Nov; 36(11):814-20. PubMed ID: 24507391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene transfer of hepatocyte growth factor by electroporation reduces bleomycin-induced lung fibrosis.
    Gazdhar A; Fachinger P; van Leer C; Pierog J; Gugger M; Friis R; Schmid RA; Geiser T
    Am J Physiol Lung Cell Mol Physiol; 2007 Feb; 292(2):L529-36. PubMed ID: 17056705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apoptotic cell instillation after bleomycin attenuates lung injury through hepatocyte growth factor induction.
    Lee YJ; Moon C; Lee SH; Park HJ; Seoh JY; Cho MS; Kang JL
    Eur Respir J; 2012 Aug; 40(2):424-35. PubMed ID: 22441736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intratracheal administration of activated protein C inhibits bleomycin-induced lung fibrosis in the mouse.
    Yasui H; Gabazza EC; Tamaki S; Kobayashi T; Hataji O; Yuda H; Shimizu S; Suzuki K; Adachi Y; Taguchi O
    Am J Respir Crit Care Med; 2001 Jun; 163(7):1660-8. PubMed ID: 11401891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidermal growth factor receptor tyrosine kinase inhibition augments a murine model of pulmonary fibrosis.
    Suzuki H; Aoshiba K; Yokohori N; Nagai A
    Cancer Res; 2003 Aug; 63(16):5054-9. PubMed ID: 12941834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EM703 improves bleomycin-induced pulmonary fibrosis in mice by the inhibition of TGF-beta signaling in lung fibroblasts.
    Li YJ; Azuma A; Usuki J; Abe S; Matsuda K; Sunazuka T; Shimizu T; Hirata Y; Inagaki H; Kawada T; Takahashi S; Kudoh S; Omura S
    Respir Res; 2006 Jan; 7(1):16. PubMed ID: 16438734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatocyte Growth Factor Is Required for Mesenchymal Stromal Cell Protection Against Bleomycin-Induced Pulmonary Fibrosis.
    Cahill EF; Kennelly H; Carty F; Mahon BP; English K
    Stem Cells Transl Med; 2016 Oct; 5(10):1307-1318. PubMed ID: 27388243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A TSP-1 synthetic peptide inhibits bleomycin-induced lung fibrosis in mice.
    Chen Y; Wang X; Weng D; Tian L; Lv L; Tao S; Chen J
    Exp Toxicol Pathol; 2009 Jan; 61(1):59-65. PubMed ID: 18579356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon-gamma upregulates the c-Met/hepatocyte growth factor receptor expression in alveolar epithelial cells.
    Nagahori T; Dohi M; Matsumoto K; Saitoh K; Honda ZI; Nakamura T; Yamamoto K
    Am J Respir Cell Mol Biol; 1999 Oct; 21(4):490-7. PubMed ID: 10502559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intratracheal administration of hepatocyte growth factor/scatter factor stimulates rat alveolar type II cell proliferation in vivo.
    Panos RJ; Patel R; Bak PM
    Am J Respir Cell Mol Biol; 1996 Nov; 15(5):574-81. PubMed ID: 8918364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted gene transfer of hepatocyte growth factor to alveolar type II epithelial cells reduces lung fibrosis in rats.
    Gazdhar A; Temuri A; Knudsen L; Gugger M; Schmid RA; Ochs M; Geiser T
    Hum Gene Ther; 2013 Jan; 24(1):105-16. PubMed ID: 23134111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance of fibrogenic responses to glucocorticoid and 2-methoxyestradiol in bleomycin-induced lung fibrosis in mice.
    Langenbach SY; Wheaton BJ; Fernandes DJ; Jones C; Sutherland TE; Wraith BC; Harris T; Schuliga MJ; McLean C; Stewart AG
    Can J Physiol Pharmacol; 2007 Jul; 85(7):727-38. PubMed ID: 17823636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.